Supernus Pharmaceuticals (SUPN)
Add to Watchlists Create an AlertSUPN Key Stats
| Income Statement | |
| Revenue TTM | 1.479M |
| Revenue Quarterly YoY Growth | 2493% |
| EPS Diluted TTM | -7.716 |
| EPS Diluted Quarterly YoY Growth | |
| Net Income TTM | -46.28M |
| Profitability | |
| Gross Profit Margin Quarterly | |
| Profit Margin Quarterly | -1241% |
| Dividend | |
| Dividend Yield | 0.00% |
| Payout Ratio TTM Pro | Go Pro |
| Current Valuation | |
| Market Cap | 210.70M |
| Enterprise Value | 139.56M |
| PE Ratio TTM | |
| PE 10 Pro | Go Pro |
| PEG Ratio | |
| Price / Book Value | 3.660 |
| Other | |
| Beta Pro | Go Pro |
| Debt to Equity Ratio | 0.3977 |
| Free Cash Flow | -16.34M |
| Return on Equity | -178.2% |
SUPN News
- Nasdaq stocks posting largest percentage increases May 20
- Supernus to Present at Two Investor Conferences GlobeNewswire May 20
- SUPERNUS PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Stateme... May 20
- 5 Stocks Setting Up to Break Out May 17
- Supernus (SUPN) PT Trimmed at Jefferies, But Survey Shows Significant Market Opp... May 17
- SUPERNUS PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report May 15
- 8 Stocks Under $10 Trending Sharply Higher May 14
- 8 Stocks Under $10 Trending Sharply Higher May 14
- Narrower-than-Expected Loss at Supernus May 14
- Narrower-than-Expected Loss at Supernus - Analyst Blog Zacks May 14
SUPN Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Supernus Pharmaceuticals is up 13.88% over the last year vs S&P 500 Total Return up 27.96%, Pernix Therapeutics down 48.32%, and Catalyst Pharmaceutical Partners down 1.14%.
SUPN Fundamentals
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Cash Flow Statement View Statement
You may also be interested in these SUPN related companies
Pro Ratings for SUPN
Pro Report PDF for SUPN
Download Pro Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.
Download SUPN Pro Report PDF
Pro Strategies Featuring SUPN
Did Supernus Pharmaceuticals make it into our Pro Portfolio Strategies?
SUPN Profile
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Other SUPN Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership MSN Money
- SEC Filings SEC
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| SUPN | 6.82 | +0.17 | +2.56% | 210.70M |
